β¨ Medicines and Appointments
3946 NEW ZEALAND GAZETTE, No. 144 24 OCTOBER 2013
Product: iQuit
Active Ingredient: Nicotine polacrilex 11.44mg equivalent to Nicotine 2mg
Dosage Form: Chewing gum
New Zealand Sponsor: Actavis New Zealand Limited
Manufacturer: Watson Laboratories Inc, New York, United States of America
Product: iQuit
Active Ingredient: Nicotine polacrilex 22.89mg equivalent to Nicotine 4mg
Dosage Form: Chewing gum
New Zealand Sponsor: Actavis New Zealand Limited
Manufacturer: Watson Laboratories Inc, New York, United States of America
Product: Lumigan PF
Active Ingredient: Bimatoprost 0.3mg/mL
Dosage Form: Eye drops, solution
New Zealand Sponsor: Allergan New Zealand Limited
Manufacturers: Allergan Pharmaceuticals Ireland, County Mayo, Ireland
Allergan Sales LLC, Texas, United States of America
Product: Picato
Active Ingredient: Ingenol mebutate 0.015%w/w
Dosage Form: Topical gel
New Zealand Sponsor: LEO Pharma Limited
Manufacturers: LEO Laboratories Limited, Dublin, Ireland
DPT Laboratories Limited, Texas, United States of America
Product: Picato
Active Ingredient: Ingenol mebutate 0.05%w/w
Dosage Form: Topical gel
New Zealand Sponsor: LEO Pharma Limited
Manufacturers: LEO Laboratories Limited, Dublin, Ireland
DPT Laboratories Limited, Texas, United States of America
Dated this 16th day of October 2013.
DR JOHN CRAWSHAW, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go6771
Internal Affairs Primary Industries
Crown Entities Act 2004
Fire Service Act 1975 Animal Products Act 1999
Appointment to the New Zealand Fire Service Commission
Pursuant to section 28(1)(a) of the Crown Entities Act 2004 and section 6 of the Fire Service Act 1975, I have appointed
Vicki Ann Caisley
as a member of the New Zealand Fire Service Commission for a term commencing on 1 December 2013 and concluding on 30 November 2016.
Dated at Wellington this 17th day of October 2013.
HON CHRIS TREMAIN, Minister of Internal Affairs.
go6813
Notice Under the Animal Products Act 1999 (Notice No. MPI 257)
Pursuant to section 41 of the Animal Products Act 1999, I hereby give notice of the issue of the Animal Products (Emergency Control Scheme β Buparvaquone) Order 2013, which I signed in my role as Minister for Food Safety, and the Animal Products (Emergency Control Scheme β Buparvaquone) Amendment Order 2013.
The principle order came into force on 4 October 2013 in relation to persons affected who were supplied with a copy of that order by that date and will come into force for all other persons on the day after the day these orders are notified in the New Zealand Gazette.
The amendment order comes into force on the day after the day these orders are notified in the New Zealand Gazette.
A copy of these orders may be inspected free of charge at, or obtained at, the office of the Ministry for Primary Industries,
Next Page →
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare16 October 2013
Medicines Act 1981, New Medicines, Distribution Consent, Nicotine polacrilex, Bimatoprost, Ingenol mebutate
- DR JOHN CRAWSHAW, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
βοΈ Appointment to the New Zealand Fire Service Commission
βοΈ Justice & Law Enforcement17 October 2013
Crown Entities Act 2004, Fire Service Act 1975, Fire Service Commission, Appointment
- Vicki Ann Caisley, Appointed member of the New Zealand Fire Service Commission
- HON CHRIS TREMAIN, Minister of Internal Affairs
πΎ Notice Under the Animal Products Act 1999
πΎ Primary Industries & ResourcesAnimal Products Act 1999, Emergency Control Scheme, Buparvaquone
NZ Gazette 2013, No 144